| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | 6.954 | 3.241 | 767 | - | - |
| Total Income - EUR | - | - | - | - | - | 11.351 | 16.609 | 5.633 | - | - |
| Total Expenses - EUR | - | - | - | - | - | 5.674 | 22.521 | 8.096 | - | - |
| Gross Profit/Loss - EUR | - | - | - | - | - | 5.677 | -5.912 | -2.463 | - | - |
| Net Profit/Loss - EUR | - | - | - | - | - | 5.608 | -5.935 | -2.473 | - | - |
| Employees | - | - | - | - | - | 1 | 1 | 1 | - | - |
Check the financial reports for the company - Pentatherapy S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | 21.347 | 17.443 | 12.560 | - | - |
| Current Assets | - | - | - | - | - | 5.739 | 8.059 | 7.507 | - | - |
| Inventories | - | - | - | - | - | 1.077 | 607 | 609 | - | - |
| Receivables | - | - | - | - | - | 3.948 | 7.048 | 6.900 | - | - |
| Cash | - | - | - | - | - | 714 | 404 | -2 | - | - |
| Shareholders Funds | - | - | - | - | - | 5.649 | -126 | -2.599 | - | - |
| Social Capital | - | - | - | - | - | 41 | 40 | 41 | - | - |
| Debts | - | - | - | - | - | 7.444 | 8.209 | 10.106 | - | - |
| Income in Advance | - | - | - | - | - | 13.993 | 17.443 | 12.560 | - | - |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8690 - 8690" | |||||||||
| CAEN Financial Year |
8690
|
|||||||||
Comments - Pentatherapy S.r.l.